BridgeMD
New treatment option for Pulmonary Disease, Chronic Obstructive
Official title Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
ClinicalTrials.gov ID: NCT05730088
What this study is testing
- What it's testing
- Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Being diagnosed with stage 4 (group D) COPD according to GOLD criteria
- Being 18 years or older,
- Having a video computer, tablet or phone,
- Having an internet connection at home or on the phone,
- Residing in the city centre of Konya,
You likely can't join if
- Being illiterate,
- Being diagnosed with first, second and third-stage COPD according to GOLD criteria,
- Having another lung disease in addition to COPD (Lung cancer-Asthma, etc.),
- Having physical and/or mental disabilities,
- Being visually impaired and/or hearing impaired,
- Having a communication problem that prevents participation in the research, such as an inability to understand/speak Turkish,
See the full eligibility criteria
- Being diagnosed with stage 4 (group D) COPD according to GOLD criteria
- Being 18 years or older,
- Having a video computer, tablet or phone,
- Having an internet connection at home or on the phone,
- Residing in the city centre of Konya,
- Not having a communication problem, such as an inability to understand/speak Turkish, that would prevent participation in the research,
- Being literate,
- Using an oxygen concentrator at home.
- Being illiterate,
- Being diagnosed with first, second and third-stage COPD according to GOLD criteria,
- Having another lung disease in addition to COPD (Lung cancer-Asthma, etc.),
- Having physical and/or mental disabilities,
- Being visually impaired and/or hearing impaired,
- Having a communication problem that prevents participation in the research, such as an inability to understand/speak Turkish,
- Having been diagnosed with Covid-19 or having had it in the past,
- Having a psychiatric disease
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Turkey (Türkiye)
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.